SGD Pharma introduces new range of Type I tubular vials EP News Bureau Feb 5, 2024 It features Corning’s Velocity Vial coating technology
Merck seeks to develop novel T-cell engager therapies with TriTAC platform: GlobalData EP News Bureau Feb 5, 2024 The deal includes the novel HPN-217 and HPN-328 compounds, which are currently undergoing Phase II clinical trials for various…
OCTF’s Consensus guidelines for HNC recognised among 13 worldwide clinical practice guidelines EP News Bureau Feb 5, 2024 The second, updated edition was officially launched at the fourth edition of the OCTF Conference in July 2023
Indo-German Chamber of Commerce, ACHEMA organise event called ‘Catalysts of Change’ for process… EP News Bureau Feb 2, 2024 This event served as a prelude to the ACHEMA 2024, a forum and platform for the process industries scheduled for June 2024 in…
Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African… EP News Bureau Feb 2, 2024 Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78 per…
Industry lauds Union Budget’s focus on Women’s Health EP News Bureau Feb 1, 2024 Overall, the Union Budget 2024 reflects a forward-looking approach OPPI commends the Government's approach towards the healthcare…
Lupin gets US FDA nod for Dronedarone Tablets, USP EP News Bureau Feb 1, 2024 They are indicated to reduce the risk of hospitalisation for atrial fibrillation (AF) in patients in sinus rhythm with a history…
Drug price controls and emphasis on preventive care top solutions to address healthcare inflation:… EP News Bureau Feb 1, 2024 Inflation in healthcare refers to the persistent increase in the cost of medical goods and services over time. This phenomenon is…
Express Pharma February 2024 EP News Bureau Feb 1, 2024 India's Foremost Pharma & Biotech Magazine ~ Cell And Gene Therapies: The Next Frontier?
Glenmark partners with Pfizer to launch Abrocitinib in India EP News Bureau Jan 31, 2024 When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively